References

Related Pages

NSTOP Pishin Checking Finger Marking of a Nomadic Child

  1. Progress Toward Poliomyelitis Eradication — Pakistan, January 2020–July 2021
    October 2021
  2. Progress Toward Polio Eradication — Worldwide, January 2019–June 2021
    August 2021
  3. Surveillance to Track Progress Toward Polio Eradication — Worldwide, 2019–2020
    May 2021
  4. Serotype 2 oral poliovirus vaccine (OPV2) choices and the consequences of delaying outbreak responseexternal icon
    May 2021
  5. The impact of disruptions caused by the COVID-19 pandemic on global polio eradicationexternal icon
    April 2021
  6. Updated Characterization of Outbreak Response Strategies for 2019-2029: Impacts of Using a Novel Type 2 Oral Poliovirus Vaccine Strainexternal icon
    February 2021
  7. Impact of COVID-19 Pandemic on Global Poliovirus Surveillanceexternal icon
    January 2021
  1. Progress Toward Poliomyelitis Eradication — Pakistan, January 2019−September 2020external icon
    November 2020
  2. Randomized Controlled Clinical Trial of bivalent Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine in Nigerian Children.external icon
    November 2020
  3. Immunogenicity of reduced-dose monovalent type 2 oral poliovirus vaccine in Mocuba, Mozambique.external icon
    November 2020
  4. Progress Toward Poliomyelitis Eradication — Afghanistan, January 2019–July 2020
    October 2020
  5. Strengthening National Immunization Technical Advisory Groups in resource-limited settings: current and potential linkages with polio national certification committeesexternal icon
    October 2020
  6. Progress Toward Poliovirus Containment Implementation — Worldwide, 2019–2020
    September 2020
  7. Notes from the Field: CDC Polio Surge Response to Expanding Outbreaks of Type 2 Circulating Vaccine-Derived Poliovirus — Africa and Philippines, September 2019–March 2020external icon
    August 2020
  8. One-year decline of poliovirus antibodies following fractional-dose inactivated poliovirus vaccine.external icon
    August 2020
  9. Update on Immunodeficiency-Associated Vaccine-Derived Polioviruses — Worldwide, July 2018–December 2019
    July 2020
  10. The Long and Winding Road to Eradicate Vaccine-Related Polioviruses.external icon
    July 2020
  11. Estimating population immunity to poliovirus in Lebanon: Results from a seroprevalence survey, 2016.external icon
    June 2020
  12. Progress Toward Polio Eradication — Worldwide, January 2018–March 2020
    June 2020
  13. Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, July 2019–February 2020external icon
    April 2020
  14. Surveillance to Track Progress Toward Polio Eradication — Worldwide, 2018–2019
    May 2020
  15. New analytic approaches for analyzing and presenting polio surveillance data to supplement standard performance indicators.external icon
    April 2020
  16. Modeling Poliovirus Transmission in Borno and Yobe, Northeast Nigeria.external icon
    April 2020
  17. Evolving epidemiology of poliovirus serotype 2 following withdrawal of the type 2 oral poliovirus vaccine.external icon
    March 2020
  18. Immunogenicity of Intramuscular Fractional Dose of Inactivated Poliovirus Vaccine.external icon
    March 2020
  19. Assessment of immunity to polio among Rohingya children in Cox’s Baar, Bangladesh, 2018: A cross-sectional survey.external icon
    March 2020
  20. Global Transmission of Live Polioviruses: Updated Dynamic Modeling of the Polio endgame.external icon
    January 2020
  1. Estimating population immunity to poliovirus in Jordan’s high-risk areas.external icon
    November 2019
  2. Inactivated Poliovirus Vaccine Supply Shortage: Is There Light at the End of the Tunnel?external icon
    April 2019
  3. Update on Vaccine-Derived Poliovirus Outbreaks – Democratic Republic of the Congo and Horn of Africa, 2017-2018.external icon
    March 2019
  4. Poliovirus immunity among children under five years-old in accessible areas of Afghanistan, 2013.external icon
    February 2019
  5. Poliovirus type 2 seroprevalence following full or fractional-dose of inactivated poliovirus vaccine in the period after Sabin type 2 withdrawal in Sri Lanka.external icon
    January 2019
Page last reviewed: September 28, 2021
Content source: Global Immunization